0001822886
true
FY
00-0000000
0001822886
2021-01-01
2021-12-31
0001822886
HHGCU:UnitsMember
2021-01-01
2021-12-31
0001822886
HHGCU:OrdinarySharesMember
2021-01-01
2021-12-31
0001822886
us-gaap:WarrantMember
2021-01-01
2021-12-31
0001822886
us-gaap:RightsMember
2021-01-01
2021-12-31
0001822886
2021-06-30
0001822886
2022-03-03
0001822886
2021-12-31
0001822886
2020-12-31
0001822886
2020-07-16
2020-12-31
0001822886
us-gaap:CommonStockMember
2020-12-31
0001822886
us-gaap:AdditionalPaidInCapitalMember
2020-12-31
0001822886
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2020-12-31
0001822886
us-gaap:RetainedEarningsMember
2020-12-31
0001822886
us-gaap:CommonStockMember
2020-07-15
0001822886
us-gaap:AdditionalPaidInCapitalMember
2020-07-15
0001822886
us-gaap:RetainedEarningsMember
2020-07-15
0001822886
2020-07-15
0001822886
us-gaap:CommonStockMember
2021-01-01
2021-12-31
0001822886
us-gaap:AdditionalPaidInCapitalMember
2021-01-01
2021-12-31
0001822886
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2021-01-01
2021-12-31
0001822886
us-gaap:RetainedEarningsMember
2021-01-01
2021-12-31
0001822886
us-gaap:CommonStockMember
2020-07-16
2020-12-31
0001822886
us-gaap:AdditionalPaidInCapitalMember
2020-07-16
2020-12-31
0001822886
us-gaap:RetainedEarningsMember
2020-07-16
2020-12-31
0001822886
us-gaap:CommonStockMember
2021-12-31
0001822886
us-gaap:AdditionalPaidInCapitalMember
2021-12-31
0001822886
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2021-12-31
0001822886
us-gaap:RetainedEarningsMember
2021-12-31
0001822886
us-gaap:IPOMember
2021-09-22
2021-09-23
0001822886
us-gaap:OverAllotmentOptionMember
2021-09-22
2021-09-23
0001822886
us-gaap:IPOMember
2021-09-23
0001822886
us-gaap:PrivatePlacementMember
2021-09-22
2021-09-23
0001822886
us-gaap:PrivatePlacementMember
2021-09-23
0001822886
HHGCU:PrivateUnitsMember
2021-09-22
2021-09-23
0001822886
HHGCU:AmericanStockAndTrustCompanyLLCMember
2021-09-22
2021-09-23
0001822886
2021-09-23
0001822886
us-gaap:USTreasurySecuritiesMember
2021-12-31
0001822886
2020-06-15
2020-12-31
0001822886
HHGCU:CommonSharesSubjectToRedemptionMember
2021-01-01
2021-12-31
0001822886
HHGCU:CommonSharesNotSubjectToRedemptionMember
2021-01-01
2021-12-31
0001822886
HHGCU:CommonSharesSubjectToRedemptionMember
2020-07-16
2020-12-31
0001822886
HHGCU:CommonSharesNotSubjectToRedemptionMember
2020-07-16
2020-12-31
0001822886
HHGCU:UnderwriterMember
2021-09-22
2021-09-23
0001822886
HHGCU:PublicSharesMember
2021-09-23
0001822886
HHGCU:PublicWarrantsAndPublicRightsMember
2021-09-23
0001822886
HHGCU:PublicUnitsMember
2021-12-31
0001822886
HHGCU:PublicWarrantsAndPublicRightsMember
2021-12-31
0001822886
us-gaap:PrivatePlacementMember
2021-01-01
2021-12-31
0001822886
us-gaap:PrivatePlacementMember
2021-12-31
0001822886
HHGCU:FounderMember
2020-07-01
2020-07-31
0001822886
HHGCU:FounderMember
2020-11-01
2020-11-30
0001822886
HHGCU:FounderMember
2021-02-01
2021-02-28
0001822886
us-gaap:IPOMember
us-gaap:AdministrativeServiceMember
2021-01-01
2021-12-31
0001822886
us-gaap:IPOMember
us-gaap:AdministrativeServiceMember
2020-01-01
2020-12-31
0001822886
HHGCU:PromissoryNoteMember
HHGCU:HHGFundMember
2021-02-01
2021-02-28
0001822886
HHGCU:PromissoryNoteMember
2021-02-01
2021-02-28
0001822886
HHGCU:HHGFundMember
2021-04-19
2021-04-20
0001822886
HHGCU:HHGFundMember
2021-09-29
2021-09-30
0001822886
HHGCU:PromissoryNoteMember
2021-12-31
0001822886
HHGCU:PromissoryNoteMember
2020-12-31
0001822886
HHGCU:AdministrativeServicesAgreementMember
2021-01-01
2021-12-31
0001822886
us-gaap:WarrantMember
2021-12-31
0001822886
HHGCU:BusinessAcquisitionMember
2021-01-01
2021-12-31
0001822886
srt:MaximumMember
2021-01-01
2021-12-31
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
xbrli:pure
(Amendment No. 1)
NOTE
1 - ORGANIZATION AND BUSINESS BACKGROUND
HHG
Capital Corporation (the “Company” or “we”, “us” and “our”) is a newly organized blank
check company incorporated on July 15, 2020, under the laws of the British Virgin Islands for the purpose of acquiring, engaging in a
share exchange, share reconstruction and amalgamation, purchasing all or substantially all of the assets of, entering into contractual
arrangements, or engaging in any other similar business combination with one or more businesses or entities (“Business Combination”).
Currently, the Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination,
except for any entity with its principal business operations in China (including Hong Kong).
From
inception through December 31, 2021, the Company had not yet commenced any operations. All activity through December 31, 2021 relates
to the Company’s formation and the Initial Public Offering as described below. The Company has selected December 31 as its fiscal
year end.
Financing
The
registration statement for the Company’s Initial Public Offering (the “Initial Public Offering” or “IPO”
as described in Note 4) became effective on September 20, 2021. On September 23, 2021, the Company consummated the Initial Public Offering
of 5,000,000 ordinary units (the “Public Units”), generating gross proceeds of $50,000,000 which is described in Note 4.
Simultaneously,
the underwriters exercised the over-allotment option in full. The underwriters purchased an additional 750,000 Units (the “Over-Allotment
Units”) at an offering price of $10.00 per Unit, generating gross proceeds to the Company of $7,500,000.
Simultaneously
with the closing of the Initial Public Offering, the Company consummated the sale of 237,000 units (the “Private Units”)
at a price of $10.00 per Private Unit in a private placement, generating gross proceeds of $2,370,000, which is described in Note 5.
On September 23, 2021, simultaneously with the sale of the over-allotment units, the Company consummated the private sale of an additional
18,000 Private Units, generating gross proceeds of $180,000.
Transaction
costs paid upon the consummation of the Initial Public Offering amounted to $1,031,411, consisting of $805,000 of underwriter’s
fees and $226,411 of other offering costs.
Trust
Account
Upon
the closing of the Initial Public Offering, the exercise of the over-allotment option and the closing of the private placement, $58,075,000
was placed in a trust account (the “Trust Account”) with American Stock & Trust Company, LLC acting as trustee. The funds
held in the Trust Account can be invested in United States government treasury bills, bonds or notes, having a maturity of 180 days or
less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act until the earlier
of (i) the consummation of the Company’s initial Business Combination and (ii) the Company’s failure to consummate a Business
Combination within the Combination Period as described below. Placing funds in the Trust Account may not protect those funds from third
party claims against the Company. Although the Company will seek to have all vendors, service providers, prospective target businesses
or other entities it engages, execute agreements with the Company waiving any claim of any kind in or to any monies held in the Trust
Account, there is no guarantee that such persons will execute such agreements. The remaining net proceeds (not held in the Trust Account)
may be used to pay for business, legal and accounting due diligence on prospective acquisitions and continuing general and administrative
expenses. Additionally, the interest earned on the Trust Account balance may be released to the Company to pay the Company’s tax
obligations.
Business
Combination
Pursuant
to Nasdaq listing rules, the Company’s initial Business Combination must occur with one or more target businesses having an aggregate
fair market value equal to at least 80% of the value of the funds in the Trust Account (excluding any deferred underwriter’s fees
and taxes payable on the income earned on the Trust Account), which the Company refers to as the 80% test, at the time of the execution
of a definitive agreement for our initial Business Combination, although the Company may structure a Business Combination with one or
more target businesses whose fair market value significantly exceeds 80% of the Trust Account balance. If the Company is no longer listed
on Nasdaq, it will not be required to satisfy the 80% test. The Company currently anticipates structuring a Business Combination to acquire
100% of the equity interests or assets of the target business or businesses.
The
Company will provide its shareholders with the opportunity to redeem all or a portion of their ordinary shares obtained in the Initial
Public Offering (“Public Shares”) upon the completion of a Business Combination either (i) in connection with a shareholder
meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek
shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The shareholders
will be entitled to redeem their Public Shares for a pro rata portion of the amount then on deposit in the Trust Account (initially $10.10
per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay
its tax obligations). The per-share amount to be distributed to shareholders who redeem their shares will not be reduced by the deferred
underwriting commissions the Company will pay to the underwriters (as discussed in Note 6). There will be no redemption rights upon the
completion of a Business Combination with respect to the Company’s warrants and rights. The ordinary shares subject to redemption
was initially recorded at its fair value at the date of issuance and classified as temporary equity upon the completion of the Initial
Public Offering, in accordance with Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities
from Equity.”
The
Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation
of a Business Combination and, if the Company seeks shareholder approval, a majority of the outstanding shares voted are voted in favor
of the Business Combination. If a shareholder vote is not required and the Company does not decide to hold a shareholder vote for business
or other legal reasons, the Company will, pursuant to its Second Amended and Restated Memorandum and Articles of Association, offer such
redemption pursuant to the tender offer rules of the Securities and Exchange Commission (“SEC”), and file tender offer documents
containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination.
The
Company’s initial shareholders (the “initial shareholders”) have agreed (a) to vote their insider shares, the ordinary
shares included in the Private Units (the “Private Shares”) and any Public Shares purchased during or after the Initial Public
Offering in favor of a Business Combination, (b) not to propose, or vote in favor of, an amendment to the Company’s Second Amended
and Restated Memorandum and Articles of Association that would stop the public shareholders from converting or selling their shares to
the Company in connection with a Business Combination or affect the substance or timing of the Company’s obligation to redeem 100%
of the Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) unless
the Company provides dissenting public shareholders with the opportunity to convert their Public Shares into the right to receive cash
from the Trust Account in connection with any such vote; (c) not to convert any insider shares and Private Units (including underlying
securities) (as well as any Public Shares purchased during or after the Initial Public Offering) into the right to receive cash from
the Trust Account in connection with a shareholder vote to approve a Business Combination (or sell any shares in a tender offer in connection
with a Business Combination) or a vote to amend the provisions of the Second Amended and Restated Memorandum and Articles of Association
relating to shareholders’ rights of pre-Business Combination activity and (d) that the insider shares and Private Units (including
underlying securities) shall not participate in any liquidating distributions upon winding up if a Business Combination is not consummated.
However, the initial shareholders will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares
purchased during or after the Initial Public Offering if the Company fails to complete its Business Combination. The Company will have
until 12 months (or 15 months if the Company has filed a proxy statement, registration statement or similar filing for an initial business
combination within 12 months from the consummation of the Initial Public Offering but have not completed the initial business combination
within such 12-month period, or up to 21 months if the Company extends the period of time to consummate a business combination, as described
in more detail in this prospectus) from the closing of the Initial Public Offering to complete its Business Combination (the “Combination
Period”).
Liquidation
If
the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except
for the purpose of winding up, (ii) as promptly as reasonably possible but no more than ten business days thereafter, redeem 100% of
the outstanding Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account,
including interest earned (net of taxes payable), which redemption will completely extinguish public shareholders’ rights as shareholders
(including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably
possible following such redemption, subject to the approval of the remaining shareholders and the Company’s board of directors,
proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to its obligations
to provide for claims of creditors and the requirements of applicable law. The underwriters have agreed to waive its rights to the deferred
underwriting commission held in the Trust Account in the event the Company does not complete a Business Combination within the Combination
Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the
redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available
for distribution will be less than $10.10.
The
Sponsor has agreed that it will be liable to the Company, if and to the extent any claims by a vendor for services rendered or products
sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce
the amounts in the Trust Account to below $10.10 per share (whether or not the underwriters’ over-allotment option is exercised
in full), except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and
except as to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities,
including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed
waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such
third party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to
claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which
the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies
held in the Trust Account.
Liquidity
For
the year ended December 31, 2021, the Company incurred net loss of $140,520 and had negative cash generated from operating activities
of $130,305. As of December 31, 2021, the Company had cash of $779,868 and working capital of $738,244. Management believes its cash
is sufficient to support the Company’s operation for the next 12-month period from the date the accompanying financial statements
are issued.
NOTE
2 – SIGNIFICANT ACCOUNTING POLICIES
These
accompanying financial statements have been prepared in accordance with generally accepted accounting principles in the United States
of America (“U.S. GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”).
● |
Emerging
growth company |
The
Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our
Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements
that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required
to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced
disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements
of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously
approved.
Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting
standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do
not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of
such extended transition period which means that when a standard is issued or revised and it has different application dates for public
or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies
adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which
is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult
or impossible because of the potential differences in accounting standards used.
In
preparing these financial statements in conformity with U.S. GAAP, management makes estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the
reported expenses during the reporting period.
Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of
a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating
its estimate, could change in the near term due to one or more future confirming events. Accordingly, actual results may differ from
these estimates.
● |
Cash
and cash equivalents |
The
Company’s cash consists of deposit with financial institution. The Company considers all short-term investments with an original
maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of December
31, 2021 and 2020.
● |
Concentration
of credit risk |
Financial
instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution.
The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such
account.
● |
Cash
held in Trust Account |
At
December 31, 2021, the assets held in the Trust Account are held in cash and US Treasury securities. Investment securities in the Company’s
Trust Account consisted of $58,076,283 in United States Treasury Bills.
The
Company classifies marketable securities as available-for-sale at the time of purchase and reevaluates such classification as of each
balance sheet date. All marketable securities are recorded at their estimated fair value. Unrealized gains and losses for available-for-sale
securities are recorded in other comprehensive income. The Company evaluates its investments to assess whether those with unrealized
loss positions are other than temporarily impaired. Impairments are considered other than temporary if they are related to deterioration
in credit risk or if it is likely the Company will sell the securities before the recovery of the cost basis. Realized gains and losses
and declines in value determined to be other than temporary are determined based on the specific identification method and are reported
in other income (expense), net in the statements of operations.
● |
Deferred
Offering Costs |
Deferred
offering costs consist of underwriting, legal, accounting and other expenses incurred through the balance sheet date that are directly
related to the Initial public Offering and that were charged to shareholders’ equity upon the completion of the Initial Public
Offering.
The
Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s
specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards
Codification (“ASC”) 480, “Distinguishing Liabilities from Equity” (“ASC 480”) and ASC 815,
“Derivatives and Hedging” (“ASC 815”). The assessment considers whether the warrants are freestanding
financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all
of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary
shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s
control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted
at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.
For
issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component
of equity at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants
are required to be recorded as liabilities at their initial fair value on the date of issuance, and each balance sheet date thereafter.
Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the statements of operations.
As
the warrants issued upon the IPO and private placements meet the criteria for equity classification under ASC 480, therefore, the warrants
are classified as equity.
● |
Ordinary
shares subject to possible redemption |
The
Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing
Liabilities from Equity.” Ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument
and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that
are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s
control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s
ordinary shares issued upon the consummation of the IPO and the exercise of the over-allotment option feature certain redemption rights
that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at
December 31, 2021, ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders’
equity section of the Company’s balance sheet.
The
Company has made a policy election in accordance with ASC 480-10-S99-3A and recognizes changes in redemption value in accumulated deficit
over an expected 12-month period leading up to a Business Combination. On December 31, 2021, the Company had recorded $2,947,334 accretion
of carrying value to redemption value.
Income
taxes are determined in accordance with the provisions of ASC Topic 740, “Income Taxes” (“ASC 740”). Under
this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the
financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities
are measured using enacted income tax rates expected to apply to taxable income in the years in which those temporary differences are
expected to be recovered or settled. Any effect on deferred tax assets and liabilities of a change in tax rates is recognized in income
in the period that includes the enactment date.
ASC
740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their financial statements
uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the
financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. The Company’s
management determined that the British Virgin Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest
and penalties related to unrecognized tax benefits, if any, as income tax expense. There were no unrecognized tax benefits and no amounts
accrued for interest and penalties as of December 31, 2021. The Company is currently not aware of any issues under review that could
result in significant payments, accruals or material deviation from its position.
The
Company may be subject to potential examination by foreign taxing authorities in the area of income taxes. These potential examinations
may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with
foreign tax laws.
The
Company’s tax provision is zero
for the period from July 15, 2020 (date of inception)
through December 31, 2020 and for the year ended December 31, 2021.
The
Company is considered to be an exempted British Virgin Islands Company, and is presently not subject to income taxes or income tax filing
requirements in the British Virgin Islands or the United States.
The
Company complies with accounting and disclosure requirements of FASB ASC 260, Earnings Per Share. In order to determine the net income
(loss) attributable to both the redeemable shares and non-redeemable shares, the Company first considered the undistributed income (loss)
allocable to both the redeemable common stock and non-redeemable common stock and the undistributed income (loss) is calculated using
the total net loss less any dividends paid. The Company then allocated the undistributed income (loss) ratably based on the weighted
average number of shares outstanding between the redeemable and non-redeemable ordinary share. Any remeasurement of the accretion to
redemption value of the ordinary share subject to possible redemption was considered to be dividends paid to the public shareholders.
As of December 31, 2021, the Company has not considered the effect of the warrants sold in the Initial Public Offering in the calculation
of diluted net income (loss) per share, since the exercise of the warrants is contingent upon the occurrence of future events and the
inclusion of such warrants would be anti-dilutive and the Company did not have any other dilutive securities and other contracts that
could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted income
(loss) per share is the same as basic (income) loss per share for the period presented.
The
net income (loss) per share presented in the statement of operations is based on the following:
SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED
| |
December 31,
2021 | | |
through December
31, 2020 | |
| |
For the Year | | |
For the period
from | |
| |
Ended | | |
July 15, 2020
(Inception) | |
| |
December 31,
2021 | | |
through December
31, 2020 | |
Net loss | |
$ | (140,520 | ) | |
$ | (18,254 | ) |
Accretion of carrying value to redemption
value | |
| (2,947,334 | ) | |
| - | |
Net loss including accretion
of carrying value to redemption value | |
$ | (3,087,854 | ) | |
$ | (18,254 | ) |
SCHEDULE
OF EARNINGS PER SHARE BASIC AND DILUTED BY ORDINARY SHARE
| |
| | |
| | |
For the Period
from | |
| |
For the Year
Ended | | |
July 15, 2020
(Inception) | |
| |
December 31,
2021 | | |
to December
31, 2020 | |
| |
Redeemable | | |
Non-Redeemable | | |
Redeemable | | |
Non-Redeemable | |
| |
Ordinary Share | | |
Ordinary Share | | |
Ordinary Share | | |
Ordinary Share | |
Basic and diluted net income (loss) per share: | |
| | | |
| | | |
| | | |
| | |
Numerators: | |
| | | |
| | | |
| | | |
| | |
Allocation of net loss including
carrying value to redemption value | |
$ | (1,574,475 | ) | |
$ | (1,513,379 | ) | |
$ | - | | |
$ | (18,254 | ) |
Accretion of carrying value to redemption
value | |
| 2,947,334 | | |
| - | | |
| - | | |
| - | |
Allocation of net income
(loss) | |
$ | 1,372,859 | | |
$ | (1,513,379 | ) | |
$ | - | | |
$ | (18,254 | ) |
Denominators: | |
| | | |
| | | |
| | | |
| | |
Weighted-average shares outstanding | |
| 1,559,589 | | |
| 1,499,070 | | |
| - | | |
| 372,485 | |
Basic and diluted net
income (loss) per share | |
$ | 0.88 | | |
$ | (1.01 | ) | |
$ | - | | |
$ | (0.05 | ) |
● Related parties
Parties,
which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control
the other party or exercise significant influence over the other party in making financial and operational decisions. Companies are also
considered to be related if they are subject to common control or common significant influence.
● |
Fair
value of financial instrument |
FASB
ASC Topic 820 “Fair Value Measurements” defines fair value, the methods used to measure fair value and the expanded
disclosures about fair value measurements. Fair value is the price that would be received to sell an asset or paid to transfer a liability
in an orderly transaction between the buyer and the seller at the measurement date. In determining fair value, the valuation techniques
consistent with the market approach, income approach and cost approach shall be used to measure fair value. FASB ASC Topic 820 establishes
a fair value hierarchy for inputs, which represent the assumptions used by the buyer and seller in pricing the asset or liability. These
inputs are further defined as observable and unobservable inputs. Observable inputs are those that buyer and seller would use in pricing
the asset or liability based on market data obtained from sources independent of the Company. Unobservable inputs reflect the Company’s
assumptions about the inputs that the buyer and seller would use in pricing the asset or liability developed based on the best information
available in the circumstances.
The
fair value hierarchy is categorized into three levels based on the inputs as follows:
Level
1 — |
Valuations
based on unadjusted quoted prices in active markets for identical assets or liabilities that
the Company has the ability to access. Valuation adjustments and block discounts are not
being applied. Since valuations are based on quoted prices that are readily and regularly
available in an active market, valuation of these securities does not entail a significant
degree of judgment.
|
Level
2 — |
Valuations
based on (i) quoted prices in active markets for similar assets and liabilities, (ii) quoted
prices in markets that are not active for identical or similar assets, (iii) inputs other
than quoted prices for the assets or liabilities, or (iv) inputs that are derived principally
from or corroborated by market through correlation or other means.
|
Level
3 — |
Valuations
based on inputs that are unobservable and significant to the overall fair value measurement. |
The
fair value of the Company’s certain assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value
Measurements” approximates the carrying amounts represented in the balance sheets. The fair values of cash and cash equivalents,
and other current assets, accrued expenses, due to sponsor are estimated to approximate the carrying values as of December 31, 2021 due
to the short maturities of such instruments. The Company measured its cash and investments held in trust account at fair value on a recurring
basis as of December 31, 2021 and the fair value is based on Level 1 inputs.
● |
Recent
accounting pronouncements |
The
Company has considered all new accounting pronouncements and has concluded that there are no new pronouncements that may have a material
impact on the results of operations, financial condition, or cash flows, based on the current information.
NOTE
3 — CASH AND INVESTMENT HELD IN TRUST ACCOUNT
As
of December 31, 2021, investment securities in the Company’s Trust Account consisted of $58,076,283 in United States Treasury Bills.
The Company classifies its United States Treasury securities as available-for-sale. Available-for-sale marketable securities are recorded
at their estimated fair value on the accompanying December 31, 2021 balance sheet. The carrying value, including gross unrealized holding
gain as other comprehensive income and fair value of held to marketable securities on December 31, 2021 is as follows:
SCHEDULE OF CARRYING VALUE, UNREALIZED HOLDING GAIN AND FAIR VALUE OF MARKETABLE SECURITIES
| |
Cost
as of
December
31,
2021 | | |
Gross
Unrealized
Holding
Gain | | |
Fair
Value as of
December
31,
2021 | |
Available-for-sale marketable securities: | |
| | | |
| | | |
| | |
U.S.
Treasury Securities | |
$ | 58,075,959 | | |
$ | 324 | | |
$ | 58,076,283 | |
NOTE
4 – PUBLIC OFFERING
On
September 23, 2021, the Company sold 5,000,000 Public Units at a price of $10.00 per Unit. Simultaneously, the Company sold an additional
750,000 units to cover over-allotments. Each Public Unit consists of one ordinary share, one right (“Public Right”) and one
redeemable warrant (“Public Warrant”). Each Public Right will convert into one-tenth (1/10) of one ordinary share upon the
completion of the initial Business Combination. Each Public Warrant will entitle the holder to purchase three-fourth (3/4) of one ordinary
share at an exercise price of $11.50 per whole share. The Company will not issue fractional shares upon the exercise of the Public Warrant
or the conversion of the Public Right.
The
Company paid an upfront underwriting discount of $805,000, equal to 1.4% of the gross offering proceeds to the underwriter at the closing
of the Initial Public Offering, with an additional fee of $1,615,000 (the “Deferred Underwriting Discount”). The Deferred
Underwriting Discount will become payable to the underwriter from the amounts held in the Trust Account solely in the event the Company
completes its Business Combination. In the event that the Company does not close the Business Combination, the underwriter has waived
its right to receive the Deferred Underwriting Discount. The underwriter is not entitled to any interest accrued on the Deferred Underwriting
Discount.
Besides
the upfront underwriting discount of $805,000 and the Deferred Underwriting Discount of $1,615,000, the Company also incurred other offering
expenses of $297,023. The Company allocates offering costs totaled $2,717,023 between Public Shares, Public Warrants and Public Rights
based on the estimated fair value of each at the date of issuance. Accordingly, $2,284,236 offering cost was allocated to Public Shares,
$432,787 offering cost was allocated to Public Warrants and Public Rights.
As
a result of the aforementioned allocation, upon the completion of the IPO, $46,245,764 is allocated to the ordinary shares included in
the Public Units and recorded as temporary equity and $8,537,213 is allocated to the Public Warrants and Public Rights and is recorded
as part of the additional paid-in capital.
NOTE
5 – PRIVATE PLACEMENT
Simultaneously
with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) with
its sponsor of 255,000 units (the “Private Units”) at a price of $10.00 per Private Unit, generating total proceeds of $2,550,000.
Each Private Unit consists of one Private Share, one Private Right (“Private Right”) and one redeemable warrant (each, a
“Private Warrant”). Each Private Right will convert into one-tenth (1/10) of one ordinary share upon the completion of the
Business Combination. Each Private Warrant is exercisable to purchase three-fourth (3/4) of one ordinary share at a price of $11.50 per
share. The Company will not issue fractional shares upon the exercise of the Public Warrant or the conversion of the Public Right.
The
Private Units are identical to the units sold in the Initial Public Offering except with certain registration rights and transfer restrictions.
NOTE
6 – RELATED PARTY TRANSACTIONS
Insider
Shares
In
July 2020, the Company issued an aggregate of 10,000 insider shares to the initial shareholders for an aggregate purchase price of $1.
In
November 2020, the Company issued an aggregate of 1,240,000 additional insider shares to the initial shareholders for an aggregate purchase
price of $24,999.
In
February 2021, the Company issued an aggregate of 187,500 additional insider shares to the initial shareholders for an aggregate purchase
price of $18. These shares are subject to forfeiture to the extent that the underwriters’ over-allotment option is not exercised
in full or in part. As the over-allotment option was exercised in full in the IPO, none of these shares were forfeited.
Advances
from a Related Party
As
of December 31, 2021 and 2020, the Company had a temporary advance of $30,450 and $48,302 from a related party for the payment of costs
related to the Initial Public Offering and administrative expense. The balance is unsecured, interest-free and has no fixed terms of
repayment.
Promissory
Note from a Related Party
In
February 2021, the Company issued an unsecured promissory note of $500,000 (the “Promissory Note) to a related party, HHG Investment
Fund SPC – HHG Capital Fund SP (“HHG Fund”), which was a majority owner of the Company. The promissory note is unsecured,
interest-free and repayable on February 16, 2022. The Company has repaid $400,000 and $100,000 to HHG Fund on April 20, 2021 and September
30, 2021, respectively. As of December 31, 2021 and 2020, the principal amount due and owing under the Promissory Note was $0 and $0,
respectively.
Administrative
Services Agreement
The
Company is obligated, commencing from the date of the consummation of the offering, to pay the Sponsor a monthly fee of $10,000 for general
and administrative services. This agreement will terminate upon completion of the Company’s Business Combination or the liquidation
of the trust account to public shareholders.
NOTE
7 – SHAREHOLDERS’ EQUITY
On
September 23, 2021, the Company completed the Initial Public Offering and issued an aggregate of 5,750,000 Public Units and raised gross
proceeds of $57,500,000. Refer to Note 4 for details. Simultaneously, the Company completed a private placement and issued an aggregate
of 255,000 Private Units and raised gross proceeds of $2,550,000. Refer to Note 5 for details.
Ordinary
shares
The
Company is authorized to issue 500,000,000 ordinary shares at par $0.0001. Holders of the Company’s ordinary shares are entitled
to one vote for each share.
Rights
Each
holder of a right (including Public Rights and Private Rights) will automatically receive one-tenth (1/10) of one ordinary share upon
consummation of a Business Combination, even if the holder of such right redeemed all shares held by it in connection with a Business
Combination. No fractional shares will be issued upon exchange of the rights. In the event the Company will not be the surviving company
upon completion of a Business Combination, each holder of a right will be required to affirmatively convert the rights in order to receive
the one-tenth (1/10) of an ordinary share underlying each right upon consummation of a Business Combination.
If
the Company is unable to complete a Business Combination within the required time period and the Company redeems the Public Shares for
the funds held in the trust account, holders of rights will not receive any of such funds for their rights and the rights will expire
worthless.
Warrants
The
Public Warrants will become exercisable on the later of (a) the completion of a Business Combination or (b) 12 months from the closing
of the Initial Public Offering. No Public Warrants will be exercisable for cash unless the Company has an effective and current registration
statement covering the ordinary shares issuable upon exercise of the Public Warrants and a current prospectus relating to such ordinary
shares. Notwithstanding the foregoing, if a registration statement covering the ordinary shares issuable upon the exercise of the Public
Warrants is not effective within 90 days from the consummation of a Business Combination, the holders may, until such time as there is
an effective registration statement and during any period when the Company shall have failed to maintain an effective registration statement,
exercise the Public Warrants on a cashless basis pursuant to the exemption from registration provided by Section 3(a)(9) of the Securities
Act provided that such exemption is available. If an exemption from registration is not available, holders will not be able to exercise
their Public Warrants on a cashless basis. The Public Warrants will expire five years after the completion of the Business Combination,
at 5:00 p.m., New York City time, or earlier upon redemption or liquidation.
The
Company may call the warrants for redemption, in whole and not in part, at a price of $0.01 per warrant:
● |
at
any time while the Public Warrants are exercisable, |
|
|
● |
upon
not less than 30 days’ prior written notice of redemption to each Public Warrant holder, |
|
|
● |
if,
and only if, the reported last sale price of the ordinary shares equals or exceeds $16.5 per share, for any 20 trading days within
a 30 trading day period ending on the third trading day prior to the notice of redemption to Public Warrant holders, and |
|
|
● |
if,
and only if, there is a current registration statement in effect with respect to the issuance of the ordinary shares underlying such
warrants at the time of redemption and for the entire 30-day trading period referred to above and continuing each day thereafter
until the date of redemption. |
The
Private Warrants are identical to the Public Warrants underlying the Units being sold in the Initial Public Offering. The Private Warrants
(including the ordinary shares issuable upon exercise of the private warrants) will not be transferable, assignable or salable until
30 days after the completion of the initial Business Combination.
If
the Company calls the warrants for redemption, management will have the option to require all holders that wish to exercise the warrants
to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of ordinary shares issuable
upon exercise of the warrants may be adjusted in certain circumstances including in the event of a share dividend, extraordinary dividend
or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuances of ordinary shares
at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company
is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account,
holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the
Company’s assets held outside of the Trust Account with respect to such warrants. Accordingly, the warrants may expire worthless.
The
Company assessed the key terms applicable to the Public Warrants as well as the Private Warrants and classified the Public Warrants and
Private Warrants as equity in accordance with ASC 480, and ASC 815.
NOTE
8 – COMMITMENTS AND CONTINGENCIES
Risks
and Uncertainties
Management
is currently evaluating the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that
the pandemic could have a negative effect on the Company’s future financial position, results of its operations and/or search for
a target company. There has not been a significant impact as of the date of these financial statements. The financial statements do not
include any adjustments that might result from the future outcome of this uncertainty. Additionally, If the Company is unable to complete
a Business Combination within the Combination Period, the Company will cease all operations except for the purpose of winding up and
redeem 100% of the outstanding Public Shares for amount then on deposit in the Trust Account. Furthermore, the ordinary shares included
in the units offered in the IPO provide the holder redemption upon the consummation of the initial Business Combination or the liquidation.
These risks and uncertainties also impact the Company’s future financial positions, results of its operations. Please refer to
Note 1 for detail discussion of these risks and uncertainties.
Registration
Rights
The
holders of the insider shares, the Private Units (and their underlying securities) and the warrants that may be issued upon conversion
of the Working Capital Loans (and their underlying securities) are entitled to registration rights pursuant to a registration rights
agreement signed on September 20, 2021. The holders of a majority of these securities will be entitled to make up to two demands that
the Company register such securities. The holders of the majority of the insider shares can elect to exercise these registration rights
at any time commencing three months prior to the date on which these ordinary shares are to be released from escrow. The holders of a
majority of the Private Units and warrants issued in payment of Working Capital Loans made to the Company (or underlying securities)
can elect to exercise these registration rights at any time after the Company consummates a Business Combination. In addition, the holders
will have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion
of a Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
NOTE
9 – SUBSEQUENT EVENTS
In
accordance with ASC Topic 855, “Subsequent Events”, which establishes general standards of accounting for and disclosure
of events that occur after the balance sheet date but before this unaudited financial statements are issued, the Company has evaluated
all events or transactions that occurred after December 31, 2021, up through the date the Company issued the audited financial statements.